Exact Sciences schedules first quarter 2022 earnings call
Exact Sciences Corp. (Nasdaq: EXAS) announced its first quarter 2022 financial results release scheduled for April 26, 2022, after U.S. market close. A conference call will follow at 5 p.m. ET to discuss these results and business developments. The company, recognized for its advanced cancer diagnostic tests, continues to innovate in the area of cancer screening and diagnostics.
Investors can access the live webcast through its website, with an archive available post-event for those unable to attend.
- Upcoming release of Q1 2022 financial results on April 26.
- Scheduled conference call demonstrates commitment to transparency with investors.
- None.
MADISON, Wis., April 8, 2022 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leader in advanced cancer diagnostics, today announced that the company plans to release its first quarter 2022 financial results after the close of the U.S. financial markets on April 26, 2022. Following the release, company management will host a webcast and conference call at 5 p.m. ET to discuss financial results and business progress.
First quarter 2022 webcast & conference call details
Date: | Tuesday, April 26, 2022 |
Time: | 5 p.m. ET |
Webcast: | The live webcast can be accessed at www.exactsciences.com |
Telephone: | Domestic callers, dial 888-330-2384 |
International callers, dial +1 240-789-2701 | |
Access code for both domestic and international callers: 4437608 |
An archive of the webcast will be available at www.exactsciences.com. A replay of the conference call will be available by calling 800-770-2030 domestically or +1 647-362-9199 internationally. The access code for the replay of the call is 4437608. The webcast, conference call, and replay are open to all interested parties.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype tests, Exact Sciences is investing in its product pipeline to support patients before and throughout their cancer diagnosis and treatment. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.
Contact:
Megan Jones
Exact Sciences Corp.
meganjones@exactsciences.com
608-535-8815
View original content to download multimedia:https://www.prnewswire.com/news-releases/exact-sciences-schedules-first-quarter-2022-earnings-call-301520621.html
SOURCE Exact Sciences Corporation
FAQ
When will Exact Sciences release its Q1 2022 financial results?
What time is the Exact Sciences earnings call?
How can I access the Exact Sciences Q1 earnings webcast?
What is the ticker symbol for Exact Sciences?
